New avenues for the optimisation of dendritic cell-based cancer immunotherapies
A recent study from the University of Helsinki reveals that inhibiting certain adhesion receptors on the surface of dendritic cells, the main antigen-presenting cells of the immune system, enhances antitumour responses.